<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03556215</url>
  </required_header>
  <id_info>
    <org_study_id>FNO-ENT-BET</org_study_id>
    <secondary_id>MH CZ - DRO - FNOs/2016</secondary_id>
    <nct_id>NCT03556215</nct_id>
  </id_info>
  <brief_title>Balloon Eustachian Tuboplasty in Treatment of Chronic Eustachian Tube Dysfunction</brief_title>
  <official_title>Balloon Eustachian Tuboplasty in Treatment of Chronic Eustachian Tube Dysfunction</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Ostrava</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University Hospital Hradec Kralove</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital Ostrava</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The prevalence of Eustachian tube (ET) dysfunction in adults reaches 1%. It causes a feeling&#xD;
      of fullness in the ear, otalgia and hearing loss and can lead to recurrent acute otitis&#xD;
      media, development of chronic otitis media with effusion and cholesteatoma. Endoscopic&#xD;
      transnasal balloon ET dilatation is a novel surgical technique for ET dysfunction. The main&#xD;
      goal is to restore ET function by dilation its cartilaginous part leading to better&#xD;
      ventilation and drainage of the middle ear. However, its real effect in the treatment of&#xD;
      particular subgroups of patients with ET dysfunction remains unknown. Patients are mostly&#xD;
      evaluated as one group.&#xD;
&#xD;
      Adults with chronic ET dysfunction will be strictly divided into particular subgroups and&#xD;
      included in the study. Subgroups will be compared in order to identify treatment effect in&#xD;
      particular subgroups.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The prevalence of Eustachian tube (ET) dysfunction in adults reaches 1%. It causes a feeling&#xD;
      of fullness in the ear, otalgia and hearing loss and can lead to recurrent acute otitis&#xD;
      media, development of chronic otitis media with effusion and cholesteatoma. Endoscopic&#xD;
      transnasal balloon ET dilatation is a novel surgical technique for ET dysfunction. The main&#xD;
      goal is to restore ET function by dilation its cartilaginous part leading to better&#xD;
      ventilation and drainage of the middle ear. However, its real effect in the treatment of&#xD;
      particular subgroups of patients with ET dysfunction remains unknown. Patients are mostly&#xD;
      evaluated as one group.&#xD;
&#xD;
      Adults with chronic ET dysfunction will be strictly divided into particular subgroups and&#xD;
      included in the study. The otomicro(endo)scopy, symptoms severity according to VAS (Visual&#xD;
      Analogue Pain Scale), ETDQ-7 (Eustachian Tube Dysfunction Questionnaire) questionnaire,&#xD;
      tympanometry, audiometry and the possibility of Valsalva and Toynbee maneuver will be used to&#xD;
      evaluate the effect of balloon ET dilatation. Only patients with standard treatment failure&#xD;
      will be included in the study. Tuboplasty with and without myringotomy will be performed (and&#xD;
      compared) in patients with chronic otitis media with effusion. Subgroups will be compared in&#xD;
      order to find patients who could profit from the treatments the most.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">May 1, 2016</start_date>
  <completion_date type="Anticipated">November 30, 2020</completion_date>
  <primary_completion_date type="Actual">May 31, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Interventional parallel randomized controlled prospective trial</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
    <masking_description>No masking was used in the study</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Otomicro(endo)scopy</measure>
    <time_frame>36 months</time_frame>
    <description>Otomicro(endo)scopy will be used to assess the presence or absence of effusion.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Symptoms severity according to Visual Analogue Scale</measure>
    <time_frame>36 months</time_frame>
    <description>Symptoms severity will be assessed on Visual Analogue Scale (on the scale of 1-10). Visual Analogue Scale is a psychometric response scale which can be used in questionnaires. It is a measurement instrument for subjective characteristics or attitudes that cannot be directly measured.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ETDQ-7 questionnaire</measure>
    <time_frame>36 months</time_frame>
    <description>The patients will be asked to fill-in the Eustachian Tube Dysfunction Questionnaire in order to assess the symptoms of Eustachian Tube Dysfunction (ETD). The ETDQ-7 is a valid and reliable symptom score for use in adult patients with ETD. The ETDQ-7 tool consists of seven items with a scale of graduated responses ranging from 1 to 7, with &quot;1&quot; corresponding to the absence of the suggested symptom and &quot;7&quot;, to maximum symptom severity.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tympanometry</measure>
    <time_frame>36 months</time_frame>
    <description>Type of tympanometry curve (A, B, C) according to Joerger et al.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Audiometry</measure>
    <time_frame>36 months</time_frame>
    <description>Hearing loss according to WHO classification (mild, moderate, severe).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tubomanometry</measure>
    <time_frame>36 months</time_frame>
    <description>Assessment of opening pressure in Eustachian tube in mmHg.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Possibility of Valsalva and Toynbee manoeuvre</measure>
    <time_frame>36 months</time_frame>
    <description>The possibility or inability of Valsalva and Toynbee manoeuvre (yes/no)</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">55</enrollment>
  <condition>Chronic Eustachian Tube Dysfunction</condition>
  <condition>Chronic Recurrent Otitis Media</condition>
  <condition>Effusion After Tympanostomy</condition>
  <arm_group>
    <arm_group_label>Effusion, Eustachian tube dilatation device and myringotomy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients with chronic Eustachian tube dysfunction and recurrence of chronic otitis media with effusion after tympanostomy tube exclusion, intervention: balloon Eustachian tuboplasty, and myringotomy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Effusion, Eustachian tube dilatation device</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients with chronic Eustachian tube dysfunction and recurrence of chronic otitis media with effusion after tympanostomy tube exclusion, intervention: balloon Eustachian tuboplasty only (no myringotomy)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No effusion, Eustachian tube dilatation device</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients with chronic Eustachian tube dysfunction and airy middle ear (without otitis media with effusion), Eustachian tube dilatation device, no myringotomy</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Eustachian tube dilatation device</intervention_name>
    <description>Balloon Eustachian tuboplasty will be performed using a Eustachian tube dilatation device.</description>
    <arm_group_label>Effusion, Eustachian tube dilatation device</arm_group_label>
    <arm_group_label>Effusion, Eustachian tube dilatation device and myringotomy</arm_group_label>
    <arm_group_label>No effusion, Eustachian tube dilatation device</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Myringotomy</intervention_name>
    <description>Myringotomy will be performed using a standard procedure.</description>
    <arm_group_label>Effusion, Eustachian tube dilatation device and myringotomy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  adult patients with chronic Eustachian tube dysfunction lasting more than 6 months,&#xD;
             with or without recurrence of chronic otitis media with effusion after tympanostomy&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  anatomic obstruction in nasopharynx&#xD;
&#xD;
          -  nasopharyngeal cancer&#xD;
&#xD;
          -  head and neck cancer&#xD;
&#xD;
          -  other middle ear surgery except for myringotomy or tympanostomy&#xD;
&#xD;
          -  chronic suppurative otitis media&#xD;
&#xD;
          -  patients who could not undergo general anesthesia&#xD;
&#xD;
          -  patients who did not give consent to be included in the study&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>99 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pavel Komínek, prof.,MD,Ph.D.,MBA</last_name>
    <role>Study Chair</role>
    <affiliation>University Hospital Ostrava</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Martin Formánek, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital Ostrava</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Hospital Hradec Králové</name>
      <address>
        <city>Hradec Králové</city>
        <state>Hradec Králové Region</state>
        <zip>500 05</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital Ostrava</name>
      <address>
        <city>Ostrava</city>
        <state>Moravian-Silesian Region</state>
        <zip>708 52</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Czechia</country>
  </location_countries>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>May 20, 2018</study_first_submitted>
  <study_first_submitted_qc>June 13, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">June 14, 2018</study_first_posted>
  <last_update_submitted>October 5, 2020</last_update_submitted>
  <last_update_submitted_qc>October 5, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 6, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>otitis media with effusion</keyword>
  <keyword>balloon tuboplasty</keyword>
  <keyword>Eustachian tube</keyword>
  <keyword>Eustachian tube dysfunction</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Otitis</mesh_term>
    <mesh_term>Otitis Media</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>The investigators have not decided to make individual participant data available to other researchers.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

